---
title: "Syngene International Ltd (SYNGENE) — Share Price, Financials & Analysis"
symbol: "SYNGENE"
company: "Syngene International Ltd"
canonical: "https://tapetide.com/stocks/SYNGENE"
isin: "INE398R01022"
nse_symbol: "SYNGENE"
bse_code: "539268"
sector: "Healthcare"
industry: "Healthcare Services"
market_cap_cr: 15204.2
generated_at: "2026-09-13T19:39:34.785Z"
---

# Syngene International Ltd (SYNGENE)

Canonical page: https://tapetide.com/stocks/SYNGENE

## Company

- **NSE Symbol:** SYNGENE
- **BSE Code:** 539268
- **ISIN:** INE398R01022
- **Sector:** Healthcare
- **Industry:** Healthcare Services
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2015-08-11
- **CEO:** Mr. Peter James Jonathan Bains
- **Employees:** 6533
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** syngeneintl.com

## About

Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated service provider offering end-to-end drug discovery, development, and manufacturing services on a single platform (CRAMS). Total research & manufacturing infrastructure for the company is spread across 1.9 million square feet across locations.  [1]

## Latest Price

- **Price:** ₹382.65
- **Change:** -1.35 (-0.35%)
- **Open:** ₹383.25
- **Day High:** ₹383.6
- **Day Low:** ₹375.55
- **Previous Close:** ₹384
- **Volume:** 373196
- **As Of:** 2026-09-11T10:28:46+00:00

## Key Fundamentals

Observed at 2026-09-11T04:34:26.448721Z.

- **Market Cap:** ₹15204.2 Cr
- **Classification:** Smallcap
- **P/E (reported):** 70.2
- **P/E (TTM):** 69.7
- **EPS (TTM):** ₹5.49
- **EPS (reported):** ₹11.85
- **Book Value:** ₹119.9
- **Price to Book:** 3.2
- **Dividend Yield:** 0.33%
- **ROE:** 6.54%
- **ROCE:** 8.35%
- **Debt to Equity:** 0.09
- **Revenue (yearly):** ₹3809.4 Cr
- **Net Income:** ₹316.7 Cr
- **EBITDA:** ₹989.2 Cr
- **52-Week High:** ₹678.95
- **52-Week Low:** ₹375.25
- **RSI (14):** 35.57

## Tapetide Score

- **Score:** 39 / 100
- **Score date:** 2026-09-04
- **Archetype:** Expensive and Under Pressure
- **What it means:** The multiple is demanding and the trend has turned against it, without the financial strength that would justify paying up. What matters is whether the de-rating stops at the multiple or starts showing up in the numbers.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Falling
- **Percentile:** 12 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 43.63 | 9% |
| growth | 12.21 | 9% |
| momentum | 22.63 | 12% |
| ownership | 40.08 | 24% |
| quality | 50.32 | 22% |
| valuation | 43.75 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.

### Weaknesses

- Stock is trading at 3.19 times its book value
- The company has delivered a poor sales growth of 11.4% over past five years.
- Company has a low return on equity of 10.1% over last 3 years.
- Dividend payout has been low at 12.0% of profits over last 3 years

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -21.62% | -12.18% | 57.63% |
| ebitda margin growth | -67.9% | -13.38% | -15.87% | -17.03% |
| net income growth | -106.09% | -36.17% | -8% | 0% |
| revenue growth | -28.09% | 2.56% | 5% | 11% |
| roce | -104.61% | -36.74% | -37.41% | 12.08% |
| roe | -106.09% | -37.71% | 9.67% | -45.5% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 910.1 | 853.5 | 916.9 | 789.7 | 891 | 943.7 | 1018 | 874.5 | 910.6 | 917.1 | 1036.5 | 736 |
| Expenses | 656 | 622 | 600 | 619.9 | 646.2 | 660.1 | 674.4 | 668.1 | 711.1 | 707.9 | 733.1 | 645.2 |
| Operating Profit | 254.1 | 231.5 | 316.9 | 169.8 | 244.8 | 283.6 | 343.6 | 206.4 | 199.5 | 209.2 | 303.4 | 90.8 |
| OPM % | 27.92 | 27.12 | 34.56 | 21.5 | 27.47 | 30.05 | 33.75 | 23.6 | 21.91 | 22.81 | 29.27 | 12.34 |
| Other Income | 14.2 | 25.6 | 16.1 | 50.1 | 16.5 | 18.3 | 18.9 | 17.7 | 15.4 | -55.2 | 16.2 | 11.8 |
| Interest | 13 | 10.8 | 12.9 | 11.7 | 13.1 | 12.4 | 15.9 | 11.6 | 13.2 | 11.9 | 12.1 | 9.6 |
| Depreciation | 104.6 | 108.1 | 111.1 | 106.9 | 110.9 | 108.7 | 106.1 | 111.2 | 116.5 | 113.7 | 111.5 | 112.2 |
| Profit before tax | 150.7 | 138.2 | 209 | 101.3 | 137.3 | 180.8 | 240.5 | 101.3 | 85.2 | 28.4 | 196 | -19.2 |
| Tax % | 22.69 | 19.32 | 9.76 | 25.27 | 22.72 | 27.49 | 23.78 | 14.41 | 21.24 | 47.18 | 24.54 | -53.12 |
| Net Profit | 116.5 | 111.5 | 188.6 | 75.7 | 106.1 | 131.1 | 183.3 | 86.7 | 67.1 | 15 | 147.9 | -9 |
| EPS in Rs | 2.9 | 2.77 | 4.69 | 1.88 | 2.64 | 3.26 | 4.55 | 2.15 | 1.67 | 0.37 | 3.67 | -0.22 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 1423 | 1826 | 2012 | 2184 | 2604 | 3193 | 3489 | 3642 | 3739 | 3600 |
| Expenses | 949 | 1289 | 1394 | 1507 | 1861 | 2251 | 2472 | 2598 | 2817 | 2797 |
| Operating Profit | 474 | 537 | 618 | 678 | 743 | 942 | 1017 | 1045 | 921 | 803 |
| OPM % | 33 | 29 | 31 | 31 | 29 | 30 | 29 | 29 | 25 | 22 |
| Other Income | 53 | 75 | 153 | 94 | 75 | 63 | 77 | 101 | -9 | -12 |
| Interest | 23 | 32 | 35 | 28 | 24 | 45 | 47 | 53 | 49 | 47 |
| Depreciation | 131 | 164 | 219 | 274 | 310 | 366 | 426 | 433 | 453 | 454 |
| Profit before tax | 372 | 415 | 517 | 469 | 484 | 594 | 621 | 660 | 411 | 290 |
| Tax % | 18 | 20 | 20 | 14 | 18 | 22 | 18 | 25 | 23 | — |
| Net Profit | 305 | 332 | 412 | 405 | 396 | 464 | 510 | 496 | 317 | 221 |
| EPS in Rs | 7.64 | 8.29 | 10.3 | 10.12 | 9.88 | 11.57 | 12.69 | 12.33 | 7.86 | 5.49 |
| Dividend Payout % | 7 | 3 | 0 | 0 | 10 | 11 | 10 | 10 | 16 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 200 | 200 | 400 | 400 | 401 | 401 | 402 | 402 | 403 |
| Reserves | 1520 | 1768 | 1776 | 2421 | 2897 | 3217 | 3856 | 4324 | 4436 |
| Borrowings | 787 | 813 | 773 | 893 | 1022 | 815 | 555 | 578 | 458 |
| Other Liabilities | 681 | 922 | 1214 | 1169 | 1245 | 1398 | 1339 | 1491 | 1757 |
| Total Liabilities | 3189 | 3704 | 4163 | 4883 | 5564 | 5831 | 6152 | 6796 | 7055 |
| Fixed Assets | 1030 | 1377 | 2020 | 2201 | 2393 | 2667 | 2850 | 2802 | 3000 |
| CWIP | 155 | 274 | 234 | 237 | 346 | 177 | 838 | 1266 | 1046 |
| Investments | 158 | 716 | 776 | 702 | 1034 | 918 | 548 | 647 | 741 |
| Other Assets | 1846 | 1337 | 1133 | 1743 | 1790 | 2069 | 1916 | 2081 | 2268 |
| Total Assets | 3189 | 3704 | 4163 | 4883 | 5564 | 5831 | 6152 | 6796 | 7055 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 446 | 630 | 677 | 701 | 581 | 824 | 1042 | 1168 | 915 |
| Cash from Investing Activity | -349 | -646 | -424 | -629 | -611 | -653 | -494 | -744 | -839 |
| Cash from Financing Activity | -79 | -72 | -226 | 58 | -31 | -342 | -551 | -142 | -215 |
| Net Cash Flow | 18 | -88 | 28 | 130 | -62 | -172 | -4 | 281 | -138 |
| Free Cash Flow | 82 | 47 | 34 | 255 | 105 | 305 | 553 | 398 | 547 |
| CFO/OP | 111 | 135 | 127 | 116 | 92 | 102 | 115 | 123 | 107 |

### Ratios

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 68 | 68 | 72 | 79 | 71 | 61 | 46 | 53 | 50 |
| Inventory Days | 82 | 30 | 18 | 41 | 87 | 141 | 94 | 60 | 56 |
| Days Payable | 195 | 154 | 156 | 167 | 113 | 109 | 100 | 136 | 138 |
| Cash Conversion Cycle | -44 | -56 | -66 | -47 | 45 | 92 | 40 | -23 | -32 |
| Working Capital Days | -48 | -103 | -172 | -66 | -43 | -14 | -27 | -51 | -68 |
| ROCE % | — | 17 | 17 | 14 | 13 | 15 | 15 | 13 | 10 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 54.79% | 54.79% | 54.79% | 54.72% | 54.72% | 52.74% | 52.74% | 52.68% | 52.68% | 52.68% | 52.68% | 52.59% |
| FIIs | 23.55% | 21.2% | 20.92% | 20.63% | 20.72% | 20.64% | 19.47% | 16.5% | 16.31% | 14.96% | 13.9% | 11.82% |
| DIIs | 9.94% | 13.08% | 15.8% | 16.8% | 17.48% | 19.53% | 21.5% | 24.05% | 24.62% | 25.84% | 26.44% | 28.02% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 7.53% | 7.24% | 6.45% | 6.08% | 5.45% | 5.59% | 5.08% | 5.59% | 5.28% | 5.37% | 5.51% | 6.14% |
| Others | 4.18% | 3.69% | 2.03% | 1.77% | 1.62% | 1.5% | 1.21% | 1.18% | 1.1% | 1.15% | 1.46% | 1.44% |
| No. of Shareholders | 125992 | 121880 | 115850 | 120018 | 107338 | 128806 | 125090 | 142310 | 136061 | 131750 | 135605 | 142277 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 3 / 4 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 392.81 | Sell |
| EMA (10) | 391.27 | Sell |
| SMA (20) | 398.41 | Sell |
| EMA (20) | 396.38 | Sell |
| SMA (50) | 405.58 | Sell |
| EMA (50) | 407.14 | Sell |
| SMA (100) | 427.91 | Sell |
| EMA (100) | 425.91 | Sell |
| SMA (200) | 473.18 | Sell |
| EMA (200) | 470.56 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 34.74 | Neutral |
| MACD (12,26,9) | -6.11 | Sell |
| Stochastic (14,3,3) | 10.44 | Buy |
| ADX (14) | 17.64 | Neutral |
| Williams %R (14) | -83.85 | Buy |
| ATR (14) | 9.44 | Neutral |
| ROC (12) | -6.93 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 44.1 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 5 | 62.5% |
| Hold | 2 | 25% |
| Sell | 1 | 12.5% |

Based on 8 analyst ratings, observed at 2026-09-11T04:34:26.373428+00:00.

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Of Conference Call for Analysts and Investors. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 9h - Of Conference Call for Analysts and Investors.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/535c02cf-e08a-4da6-a22b-c339f987a048.pdf) |
| 8 Apr - Regulation 74(5) compliance certificate for dematerialization during quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr - Regulation 74(5) compliance certificate for dematerialization during quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/97f1af5a-1a18-4390-9d3f-fa3aa0f3c91f.pdf) |
| 6 Mar - CCO Abhijit Zutshi and CHRO Maninder S. Puri join May 1, 2026; three executives depart April 30, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 6 Mar - CCO Abhijit Zutshi and CHRO Maninder S. Puri join May 1, 2026; three executives depart April 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4ef1b18e-e522-44cc-868b-4db4084d3cac.pdf) |
| 4 May - Q4 FY2026 earnings call transcript uploaded on company website on May 4, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 4 May - Q4 FY2026 earnings call transcript uploaded on company website on May 4, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/09f6fb36-414c-43f4-b857-7dad0910d284.pdf) |
| 4 May - Q4 FY2026 earnings call transcript uploaded on company website on May 4, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 4 May - Q4 FY2026 earnings call transcript uploaded on company website on May 4, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/09f6fb36-414c-43f4-b857-7dad0910d284.pdf) |
| 30 Apr - Syngene uploaded Q4 FY26 post-earnings call audio recording on April 30, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 30 Apr - Syngene uploaded Q4 FY26 post-earnings call audio recording on April 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/48b6ec13-7ce3-4ab1-aa3e-d2a3d5c3feed.pdf) |
| 30 Apr - Syngene uploaded Q4 FY26 post-earnings call audio recording on April 30, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 30 Apr - Syngene uploaded Q4 FY26 post-earnings call audio recording on April 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/48b6ec13-7ce3-4ab1-aa3e-d2a3d5c3feed.pdf) |
| 30 Apr - Investor Presentation under Regulation 30 of SEBI (LODR) Regulations, 2015 | [Announcement under Regulation 30 (LODR)-Investor Presentation 30 Apr - Investor Presentation under Regulation 30 of SEBI (LODR) Regulations, 2015](https://www.bseindia.com/xml-data/corpfiling/AttachHis/49a5ad47-4ad8-478a-8533-079a132b7a87.pdf) |
| 30 Apr - Investor Presentation under Regulation 30 of SEBI (LODR) Regulations, 2015 | [Announcement under Regulation 30 (LODR)-Investor Presentation 30 Apr - Investor Presentation under Regulation 30 of SEBI (LODR) Regulations, 2015](https://www.bseindia.com/xml-data/corpfiling/AttachLive/49a5ad47-4ad8-478a-8533-079a132b7a87.pdf) |
| 29 Mar - Order dated Feb 6, 2026 grants refund Rs43,15,79,510 for AY2016-17; refund pending. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 29 Mar - Order dated Feb 6, 2026 grants refund Rs43,15,79,510 for AY2016-17; refund pending.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ac12f4a2-2e4e-416e-a19d-c8d8353cc67b.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-10 | [Communication Regarding Remittance Of Final Dividend For The FY 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a872014-38ed-404e-870c-3d5acf3aafd9.pdf) |
| 2026-09-01 | [Grant Of Performance Share Units Under Syngene Long Term Incentive Performance Share Plan (PSP) 2023 (Plan)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6aeb584a-5a98-4ef6-a926-e23ccc7c7c95.pdf) |
| 2026-08-25 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40e522e5-c900-442a-af5a-9c54c8c7ab97.pdf) |
| 2026-08-24 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21b86ff1-4d75-41e6-a69c-67b9b8264366.pdf) |
| 2026-08-24 | [Announcement under Regulation 30 (LODR)-Acquisition](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58aa3c55-96ec-49c6-a88c-9e7913c4040b.pdf) |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3513815-4f72-4bd9-b837-4a2556c26715.pdf) |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8f0c7ba-f53b-4171-895d-e1d4a60b3f2a.pdf) |
| 2026-07-31 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=048e47c4-c878-4f65-80f1-b0b4f2cbdf4e.pdf) |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70a8b630-5b44-49cb-b3e3-d70d69c468a0.pdf) |
| 2026-07-29 | [Board Meeting Outcome for Outcome Of The Board Meeting Held On July 29 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa3c26ae-ba3a-400f-be9f-cc08118a9bc7.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f18cbda-8f64-46dd-9414-140c7444160c.pdf) |
| 2026-04-30 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48b6ec13-7ce3-4ab1-aa3e-d2a3d5c3feed.pdf) |
| 2026-01-23 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2bce1dc-d317-4a14-b761-5527861d0922.pdf) |
| 2025-11-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=491b6d40-ebb2-48ae-bb2d-eadc5694b0ea.pdf) |
| 2025-07-24 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29392721-fbee-40c2-b185-927497096793.pdf) |
| 2025-04-24 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd6d3c47-440b-4703-bf99-bf62a06cfb63.pdf) |
| 2024-10-24 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad2455d7-9752-4509-9e4c-04f450e73a2c.pdf) |
| 2024-07-25 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2ba2af3-8c61-45f2-9755-e6cabe4ff831.pdf) |
| 2024-04-25 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c88d4ab-7578-4a43-b36d-ec794e474201.pdf) |
| 2024-01-25 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=501387a5-dcf0-4b0c-b8e5-0d60dca6837b.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-29 | [Results - Financial Results For Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=451f728e-c537-48df-a040-5736d169dd93.pdf) |
| 2026-01-22 | [Unaudited Financial Results For Quarter & Nine Months Ended December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=522207fc-02a6-4b67-bf22-141dabe09183.pdf) |
| 2025-11-05 | [Unaudited Financial Results For The Quarter & Half Year Ended September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99b98683-57d7-4cd8-8c6f-6d44eddeb95b.pdf) |
| 2025-07-23 | [Unaudited Financial Results For Quarter Ended June 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a41bff8-4ae5-4c04-9d39-e3fca5870071.pdf) |
| 2025-04-23 | [Audited Financial Results For Quarter & Year Ended March 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7fefdef-9491-4c6e-8886-9f8ea3699ce2.pdf) |
| 2025-01-23 | [Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe6ef3a6-bbeb-49b7-b170-a531d0b9fc87.pdf) |
| 2024-10-23 | [Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62d544d1-607d-4743-921e-4fcd9678ac68.pdf) |
| 2024-07-24 | [Un-Audited Financial Results For The Quarter Ended June 30, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ac99227-7feb-4c62-b4d1-a9fc2c618271.pdf) |
| 2024-04-24 | [Audited Financial Results For The Quarter And Year Ended March 31, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e56a3ee-9c93-47be-8b5d-048c44aa2a2c.pdf) |
| 2024-01-25 | [Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2023.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06208dff-c049-416f-9a2e-dfb8a5d65606.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-07-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dce7362f-915c-40a8-9bf6-9ac049615f53.pdf) |
| 2026-04-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49a5ad47-4ad8-478a-8533-079a132b7a87.pdf) |
| 2026-01-23 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53091019-7daa-44d0-bc7d-fd03b4c2899e.pdf) |
| 2025-12-17 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=afa6c845-7ab0-411a-9ea2-09d048e2db78.pdf) |
| 2025-11-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47df660d-9183-4cf3-b1a3-a77644a0c641.pdf) |
| 2025-09-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1079630b-6d97-4010-97d3-ac21ababee25.pdf) |
| 2025-07-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5e36714-6bb1-40e5-9d19-71fb01eee0c8.pdf) |
| 2025-03-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c05c612-e46b-4b47-8828-203d05a4c0ee.pdf) |
| 2025-01-23 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07ec44f4-d317-4144-a8c7-36c74b1b8ada.pdf) |
| 2024-10-23 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93d703d1-e52f-49a4-ac7f-65afd3dedc85.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2025 | [Concall - Sep 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1079630b-6d97-4010-97d3-ac21ababee25.pdf) |
| Oct 2022 | [Concall - Oct 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e94a29db-796d-437a-8301-5f36ef129d50.pdf) |
| Mar 2025 | [Concall - Mar 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2c05c612-e46b-4b47-8828-203d05a4c0ee.pdf) |
| Jul 2024 | [Concall - Jul 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8c6e5bd5-1b25-4c29-954e-190adb4f3e26.pdf) |
| Jan 2024 | [Concall - Jan 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c7ac83b2-1029-4b28-a32e-29692f1300a5.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9aef0fb3-a57b-4b56-9f45-9fb073779304.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/63157496-e12d-4ab3-8fe4-b3723913d728.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8cab37f9-ca40-4a4a-9f8e-fc34766aa674.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1a0b4de8-8883-4d0c-b761-702598dcf268.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2023-10-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4e3dc28-5863-4d7c-bffc-6cd6798b53a2.pdf) |
| 2022-10-25 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d6425a8-e08d-4fe9-8308-bb53c20d273f.pdf) |
| 2022-07-26 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e858f990-6248-43f1-8d57-2568b49299f7.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:39:34.785Z.